PARP Inhibitors Market- Global Industry Analysis and Opportunity Assessment, 2019-2029

PARP Inhibitors Market- Global Industry Analysis and Opportunity Assessment, 2019-2029

A recent market study published by Future Market Insights (FMI) offers global industry analysis of 2015-2018 and forecast for 2019-2026. The study also offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the PARP inhibitors market, the growth prospects of the market are obtained with maximum precision.
WHAT'S INCLUDED
Chapter 01 – Executive Summary
The report commences with the executive summary of the PARP inhibitors market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the PARP inhibitors market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and the definition of the PARP inhibitors market in this chapter, which will help them understand the basic information about the PARP inhibitors market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the PARP inhibitors market report.
Chapter 03 – Key Market Trends
The PARP inhibitors market report provides the key market trends that are expected to significantly impact the market growth during the forecast period. Detailed industry trends are provided in this section.
Chapter 04 – Key Success Factor
This section includes the factors that have emerged as key successful factors and the strategies adopted by key market participants. It also highlights, pipeline assessment, estimated product launches, regulatory & reimbursement scenario, which are likely to contribute to market growth.
Chapter 05 – Global PARP Inhibitors Market Demand (in Value US$ Mn) Analysis 2015-2018 and Forecast 2019-2026
This section explains the global market value analysis and forecast for the PARP inhibitors market during the forecast period. This chapter includes a detailed analysis of the historical PARP inhibitors market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2026).
Chapter 06 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the PARP inhibitors market during the forecast period. Along with the macroeconomic factors, this section also highlights the impact factors, forecast factors, Porter’s five forces analysis for the PARP inhibitors market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section. Moreover, readers will understand the key trends followed by the leading manufacturers in the PARP inhibitors market.
Chapter 07 – Global PARP Inhibitors Market Analysis 2015-2018 & 2019-2026 by Drug
Based on drug, the PARP inhibitors market is segmented into olaparib, niraparib, rucaparib, and talazoparib. Readers can find information about the key trends and developments in the PARP inhibitors market and market attractiveness analysis based on drug type.
Chapter 08 – Global PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026 by Indication
Based on indication, the PARP inhibitors market is segmented into ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer. In this chapter, readers can find information about the key trends and developments in the PARP inhibitors market and market attractiveness analysis based on indication for PARP inhibitors.
Chapter 09– Global PARP Inhibitors Market Analysis 2015-2018 & Forecast, 2019-2026 by Distribution Channel
This chapter provides details about the PARP inhibitors market on the basis of distribution channel, and has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.
Chapter 10 – Global PARP Inhibitors Market Analysis 2015-2018 & Forecast, 2019-2026 by Region
This chapter explains how the PARP inhibitors market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
Chapter 11 – North America PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
This chapter includes a detailed analysis of the growth of the North America, along with a country-wise assessment that includes the U.S. and Canada.
Chapter 12 – Latin America PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
Readers can find detailed information about several factors which are impacting the growth of the PARP inhibitors market in Latin America. This chapter also includes the growth prospects of the PARP inhibitors market in the leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.
Chapter 13 – Europe PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
Important growth prospects of the PARP inhibitors market based on its end users in several countries such as Germany, the U.K., France, Spain, Italy, and the Rest of Europe, are included in this chapter.
Chapter 14 – South Asia PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
India & Thailand are among the leading countries in the South Asia region, which are the prime subjects of assessment to obtain the growth prospects of the South Asia PARP inhibitors market in this chapter. Readers can find detailed information about the growth parameters of the South Asia PARP Inhibitors market during 2019-2026.
Chapter 15 –East Asia PARP Inhibitors Market 2015-2018 & Forecast 2019-2026
This chapter highlights the growth of the PARP inhibitors market in East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the PARP inhibitors market in East Asia.
Chapter 16 – Oceania PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania PARP inhibitors market.
Chapter 17 – MEA PARP Inhibitors Market Analysis 2015-2018 & Forecast 2019-2026
This chapter provides information about how the PARP inhibitors market will grow in the major countries in the MEA region such as GCC Countries, South Africa, Turkey, and the rest of MEA, during the forecast period.
Chapter 18 – Market Structure Analysis
In this chapter, readers can find detailed information about the tier analysis and market concentration of the key players in the PARP inhibitors market, along with their market presence analysis by region and product portfolio.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the PARP inhibitors market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are AstraZeneca and GlaxoSmithKline plc., Merck Co. & Inc., Clovis Oncology, Pfizer Inc., etc.
Chapter 20 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the PARP inhibitors market report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the PARP inhibitors market.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting The Market
4. Key Inclusions
4.1. Key Regulations
4.2. Pipeline Analysis
4.3. Epidemiology for Different Cancer, By Country
5. Global PARP Inhibitors Market Demand (in Value or Size in US$ Mn) Analysis 2015-2018 and Forecast, 2019-2026
5.1. Historical Market Value (US$ Mn) Analysis, 2015-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2026
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors - Relevance & Impact
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026, by Drug Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2015-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019-2026
7.3.1. Niraparib
7.3.2. Olaparib
7.3.3. Rucaparib
7.3.4. Talazoparib
7.4. Market Attractiveness Analysis By Drug Type
8. Global PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2018 - 2018
8.3.1. Ovarian Cancer
8.3.2. Breast Cancer
8.3.3. Prostate Cancer
8.3.4. Pancreatic Cancer
8.4. Market Attractiveness Analysis By Indication
9. Global PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2018 - 2018
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug Type
11.3.3. By Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Latin America PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Drug Type
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Europe PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Rest of Europe
13.3.2. By Drug Type
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. South Asia PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Rest of South Asia
14.3.2. By Drug Type
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. East Asia PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug Type
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Oceania PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug Type
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Middle East and Africa PARP Inhibitors Market Analysis 2015-2018 and Forecast 2019-2026
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2018
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
17.3.1. By Country
17.3.1.1. Turkey
17.3.1.2. Rest of Middle East and Africa
17.3.2. By Drug Type
17.3.3. By Indication
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Tissue Diagnostics )
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional Footprint of Players
18.4.2. Product Footprint by Players
18.4.3. Channel Footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Pricing Analysis by Competition
19.3. Competition Benchmarking
19.4. Competition Deep Dive
19.4.1. Pfizer Inc.
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Sales Footprint
19.4.1.4. Analyst commentary
19.4.2. AstraZeneca
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Sales Footprint
19.4.2.4. Analyst commentary
19.4.3. Merck & Co. Inc.
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Sales Footprint
19.4.3.4. Analyst commentary
19.4.4. GlaxoSmithKline Plc. (TESARO INC.)
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Sales Footprint
19.4.4.4. Analyst commentary
19.4.5. Clovis Oncology
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Sales Footprint
19.4.5.4. Analyst commentary
19.4.6. BeiGene
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Sales Footprint
19.4.6.4. Analyst commentary
19.4.7. Jiangsu Hengrui Medicine Co.
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Sales Footprint
19.4.7.4. Analyst commentary
19.4.8. Oncology Venture AB
19.4.8.1. Overview
19.4.8.2. Product Portfolio
19.4.8.3. Sales Footprint
19.4.8.4. Analyst commentary
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook